By Hugo Francisco de Souza A new plasma biomarker clock offers an early glimpse into Alzheimer’s timing, potentially reshaping prevention research and therapeutic trials. Study: Predicting onset of ...

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict the degeneration of neural networks in amyotrophic ...

Amyotrophic lateral sclerosis (ALS) remains one of the most devastating and biologically elusive neurodegenerative diseases. Despite decades of research, its underlying mechanisms are still not fully ...

The MarketWatch News Department was not involved in the creation of this content. AI-based digital twin modeling predicts patient-specific decline, addressing key trial design and biomarker challenges ...

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the CKD ...

Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses large-scale ...

Daniel Martínez-Pérez is investigating TSPO, a biomarker of neuroinflammation, and its role in the progression of Alzheimer's disease.

AI-based digital twin modeling predicts patient-specific decline, addressing key trial design and biomarker challenges in FSHD CHARLOTTESVILLE, Va, July 16, 2025 /PRNewswire/ - Springbok Analytics, a ...